568 related articles for article (PubMed ID: 31442407)
1. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.
Dong MB; Wang G; Chow RD; Ye L; Zhu L; Dai X; Park JJ; Kim HR; Errami Y; Guzman CD; Zhou X; Chen KY; Renauer PA; Du Y; Shen J; Lam SZ; Zhou JJ; Lannin DR; Herbst RS; Chen S
Cell; 2019 Aug; 178(5):1189-1204.e23. PubMed ID: 31442407
[TBL] [Abstract][Full Text] [Related]
2. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens.
Yim S; Hwang W; Han N; Lee D
Front Immunol; 2022; 13():884561. PubMed ID: 35651625
[TBL] [Abstract][Full Text] [Related]
3. In vivo CRISPR screening in CD8 T cells with AAV-Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma.
Ye L; Park JJ; Dong MB; Yang Q; Chow RD; Peng L; Du Y; Guo J; Dai X; Wang G; Errami Y; Chen S
Nat Biotechnol; 2019 Nov; 37(11):1302-1313. PubMed ID: 31548728
[TBL] [Abstract][Full Text] [Related]
4. Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens.
Schlabach MR; Lin S; Collester ZR; Wrocklage C; Shenker S; Calnan C; Xu T; Gannon HS; Williams LJ; Thompson F; Dunbar PR; LaMothe RA; Garrett TE; Colletti N; Hohmann AF; Tubo NJ; Bullock CP; Le Mercier I; Sofjan K; Merkin JJ; Keegan S; Kryukov GV; Dugopolski C; Stegmeier F; Wong K; Sharp FA; Cadzow L; Benson MJ
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 38099496
[TBL] [Abstract][Full Text] [Related]
5. miR-149-3p reverses CD8
Zhang M; Gao D; Shi Y; Wang Y; Joshi R; Yu Q; Liu D; Alotaibi F; Zhang Y; Wang H; Li Q; Zhang ZX; Koropatnick J; Min W
Open Biol; 2019 Oct; 9(10):190061. PubMed ID: 31594465
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc.
Chandran SS; Paria BC; Srivastava AK; Rothermel LD; Stephens DJ; Kammula US
Cancer Res; 2015 Aug; 75(16):3216-26. PubMed ID: 26100671
[TBL] [Abstract][Full Text] [Related]
7. Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies.
Roth TL; Li PJ; Blaeschke F; Nies JF; Apathy R; Mowery C; Yu R; Nguyen MLT; Lee Y; Truong A; Hiatt J; Wu D; Nguyen DN; Goodman D; Bluestone JA; Ye CJ; Roybal K; Shifrut E; Marson A
Cell; 2020 Apr; 181(3):728-744.e21. PubMed ID: 32302591
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional and epigenetic regulators of human CD8
McCutcheon SR; Swartz AM; Brown MC; Barrera A; McRoberts Amador C; Siklenka K; Humayun L; Ter Weele MA; Isaacs JM; Reddy TE; Allen AS; Nair SK; Antonia SJ; Gersbach CA
Nat Genet; 2023 Dec; 55(12):2211-2223. PubMed ID: 37945901
[TBL] [Abstract][Full Text] [Related]
9.
Wang B; Zhang W; Jankovic V; Golubov J; Poon P; Oswald EM; Gurer C; Wei J; Ramos I; Wu Q; Waite J; Ni M; Adler C; Wei Y; Macdonald L; Rowlands T; Brydges S; Siao J; Poueymirou W; MacDonald D; Yancopoulos GD; Sleeman MA; Murphy AJ; Skokos D
Sci Immunol; 2018 Nov; 3(29):. PubMed ID: 30389797
[TBL] [Abstract][Full Text] [Related]
10. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
Whitman E; Barber A
Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
[TBL] [Abstract][Full Text] [Related]
11. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1
Kurtulus S; Madi A; Escobar G; Klapholz M; Nyman J; Christian E; Pawlak M; Dionne D; Xia J; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
Immunity; 2019 Jan; 50(1):181-194.e6. PubMed ID: 30635236
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
[TBL] [Abstract][Full Text] [Related]
13. In vivo T cell CRISPR screens reveal immunotherapeutic targets.
Bradley CA
Nat Rev Cancer; 2019 Nov; 19(11):606. PubMed ID: 31492928
[No Abstract] [Full Text] [Related]
14. Integrative Expression and Prognosis Analysis of DHX37 in Human Cancers by Data Mining.
Huang K; Pang T; Tong C; Chen H; Nie Y; Wu J; Zhang Y; Chen G; Zhou W; Yang D
Biomed Res Int; 2021; 2021():6576210. PubMed ID: 33490273
[TBL] [Abstract][Full Text] [Related]
15. CD39
Tallón de Lara P; Castañón H; Vermeer M; Núñez N; Silina K; Sobottka B; Urdinez J; Cecconi V; Yagita H; Movahedian Attar F; Hiltbrunner S; Glarner I; Moch H; Tugues S; Becher B; van den Broek M
Nat Commun; 2021 Feb; 12(1):769. PubMed ID: 33536445
[TBL] [Abstract][Full Text] [Related]
16. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
17. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help.
Monjazeb AM; Tietze JK; Grossenbacher SK; Hsiao HH; Zamora AE; Mirsoian A; Koehn B; Blazar BR; Weiss JM; Wiltrout RH; Sckisel GD; Murphy WJ
PLoS One; 2014; 9(8):e102709. PubMed ID: 25119341
[TBL] [Abstract][Full Text] [Related]
18. Follicular helper-T cells restore CD8
Niogret J; Berger H; Rebe C; Mary R; Ballot E; Truntzer C; Thibaudin M; Derangère V; Hibos C; Hampe L; Rageot D; Accogli T; Joubert P; Routy B; Harker J; Vegran F; Ghiringhelli F; Chalmin F
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103351
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity.
Zhao H; Liu Y; Wang L; Jin G; Zhao X; Xu J; Zhang G; Ma Y; Yin N; Peng M
Cell Rep; 2021 Dec; 37(10):110083. PubMed ID: 34879274
[TBL] [Abstract][Full Text] [Related]
20. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
